Skip Navigation


Rheumatology Advance Access originally published online on June 7, 2006
Rheumatology 2007 46(1):49-56; doi:10.1093/rheumatology/kel170
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
46/1/49    most recent
kel170v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, Y. H.
Right arrow Articles by Harley, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Y. H.
Right arrow Articles by Harley, J. B.
Related Collections
Right arrow Fibromyalgia
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis

Y. H. Lee1, Y. H. Rho1, S. J. Choi1, J. D. Ji1, G. G. Song1, S. K. Nath2–4 and J. B. Harley2–5

1Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, College of Medicine, Korea University, Seoul, Korea, 2Arthritis and Immunology Research Program, 3Genetic Epidemiology Unit, Oklahoma Medical Research Foundation, 4University of Oklahoma Health Sciences Center and 5US Department of Veterans Affairs Medical Center, Oklahoma City, OK, USA.

Correspondence to: Young Ho Lee, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, 126-1 Ka, Anam-Dong, Seongbuk-Ku, Seoul 136-705, Korea. E-mail: lyhcgh{at}korea.ac.kr


  Abstract

Objective. To assess whether combined evidence shows the association between the protein tyrosine phosphatase non-receptor 22 (PTPN22) C1858T polymorphism and autoimmune diseases, and to summarize the effect size of the polymorphism associated with susceptibility of autoimmune diseases.

Methods. We surveyed studies on the PTPN22 C1858T polymorphism and autoimmune diseases using comprehensive Medline search and review of the references. Meta-analysis was performed for genotypes T/T (recessive effect), T/T + C/T (dominant effect) and T-allele in random effects models.

Results. Twenty-nine studies with 43 comparisons including 13 rheumatoid arthritis (RA), six systemic lupus erythematosus (SLE), six type-1 DM (T1D), three Grave's disease (GD), four inflammatory bowel diseases (IBD), three juvenile idiopathic arthritis (JIA), two psoriasis, two multiple sclerosis, two Addison's disease and two Celiac disease were available for the meta-analysis. The overall odds ratios (ORS) for T-allele, T/T and T/T + C/T genotypes were significantly increased in RA, SLE, GD and T1D (OR for T-allele = 1.58, 1.49, 1.85, 1.61, respectively, P < 0.00001). This meta-analysis showed the association between the T-allele and the T/T genotype and JIA (OR = 1.34, P = 0.03; OR = 1.97, P = 0.02) but did not reveal the association between the PTPN22 C1858T polymorphism and IBD, psoriasis, multiple sclerosis, Addison's disease and Celiac disease.

Conclusion. This meta-analysis demonstrates that the PTPN22 1858T allele confers susceptibility to RA, SLE, GD, T1D and JIA, supporting evidence of association of the PTPN22 gene with subgroup of autoimmune diseases.

KEY WORDS: PTPN22, Autoimmune diseases, Meta-analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
A. J. Phipps-Green, R. K. G. Topless, M. E. Merriman, N. Dalbeth, P. J. Gow, A. A. Harrison, J. Highton, P. B. B. Jones, L. K. Stamp, P. Harrison, et al.
No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population
Rheumatology, December 1, 2009; 48(12): 1614 - 1615.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J E Hollis-Moffatt, M E Merriman, R A Rodger, K A Rowley, P T Chapman, N Dalbeth, P J Gow, A A Harrison, J Highton, P B B Jones, et al.
Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis
Ann Rheum Dis, August 1, 2009; 68(8): 1340 - 1344.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
B. Rhodes and T. J. Vyse
The genetics of SLE: an update in the light of genome-wide association studies
Rheumatology, November 1, 2008; 47(11): 1603 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
N. Sahin, K. Aksu, S. Kamali, M. Bicakcigil, Z. Ozbalkan, I. Fresko, H. Ozer, S. Akar, A. M. Onat, V. Cobankara, et al.
PTPN22 gene polymorphism in Takayasu's arteritis
Rheumatology, May 1, 2008; 47(5): 634 - 635.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
V. Dideberg, G. Kristjansdottir, L. Milani, C. Libioulle, S. Sigurdsson, E. Louis, A.-C. Wiman, S. Vermeire, P. Rutgeerts, J. Belaiche, et al.
An insertion deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases
Hum. Mol. Genet., December 15, 2007; 16(24): 3008 - 3016.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.